AI assistant
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2025
May 15, 2025
31542_dirs_2025-05-15_50bc73df-43fe-433f-843c-ab402e554dab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2025-05-13
Reporting Person: INGENITO GARY (Chief Med. & Reg. Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-13 | Common stock, par value $0.001 per share | M | 200000 | $3.42 | Acquired | 268873 | Direct |
| 2025-05-13 | Common stock, par value $0.001 per share | S | 200000 | $23.68 | Disposed | 68873 | Direct |
| 2025-05-14 | Common stock, par value $0.001 per share | M | 44000 | $4.64 | Acquired | 112873 | Direct |
| 2025-05-14 | Common stock, par value $0.001 per share | S | 44000 | $23.63 | Disposed | 68873 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-05-13 | Options to purchase common stock | $3.42 | M | 200000 | Disposed | 2027-12-30 | Common Stock (200000) | Direct |
| 2025-05-14 | Options to purchase common stock | $4.64 | M | 44000 | Disposed | 2026-12-02 | Common Stock (44000) | Direct |
Footnotes
F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2: Represents a weighted average price for the shares sold. Shares were sold in a range between $23.325 and $23.93 per share.
F3: Represents a weighted average price for the shares sold. Shares were sold in a range between $23.44 and $24.025 per share.
F4: Options vested in three annual tranches beginning on December 30, 2021.
F5: Options vested in three annual tranches beginning on December 2, 2020.